1 Dexcom G6 CGM System User Guide, 2019. BRIEF SAFETY STATEMENT Failure to use the Dexcom G6 Continuous Glucose Monitoring System (G6) and its components according to the instructions for use provided with your device and available athttps://www.dexcom.com/en-us/safety-informationand to prop...
Deadline Nears for Decision on Medicare CGM CoverageMary K. Caffrey
That sounds very straight forward but I worry that it is not. The elephant in the room for those of us on G5 isThe Receiver. In January 2017 after the initial approval of the Dexcom G5 by Medicare, I wrote a post titled “Medicare and CGM Coverage: Love Your Receiver!” and explaine...
CG modifier must be added to the claim, only if all of the CGM coverage criteria in the Glucose Monitor LCD are met CGMs (K0554 and E2102) and related supplies (A4238 and K0553) which are classified by the Food & Drug Administration as Class III devices must include the KF modifier....
Medicare Part B has expanded coverage for warfarin patients monitoirng clotting time at home. Medicare Part B will now pay for meter training and equipment and supplies for all long-term warfarin users who monitor their prothrombin time at home with portable handheld meters. This expansion opens...
The FreeStyle Libre System is a device for continuous glucose monitoring (CGM). This device manages diabetes for patients at the age of 18 or more. This device aims to diminish the need for blood glucose testing for determining diabetes treatment. This system identifies trends and tracks and va...
“On behalf of our Medicare population, Dexcom would like to recognize and thank CMS for this policy coverage update,” said Kevin Sayer, President and CEO of Dexcom. “This update allows patients to access the full functionality of the Dexcom G5 CGM system as approved by the Food and Drug...
If a CGM falls under part B coverage but you get it at the pharmacy, can you use goodRX in conjunction with the insurance? Reply Jagger Esch says: May 2, 2022 at 7:36 am Melinda, You are never able to use insurance coverage and GoodRx. In this case, you would need to see whic...
The study found the following: fewer patients entered the coverage gap in 2007 with 15.5% entering versus 17.1% in 2006; patients are willing to stay on their branded medication while in the coverage gap for the first 60 to 90 days. However, with the average stay in the gap increasing to...
Researchers also examined the use of continuous glucose monitoring (CGM). There was a 42 percent increase per 100,000 enrollees in claims related to CGM use. Regarding specialties, they noted that primary care physicians were the most common provider of general RPM, offering 63.1 percent ...